Multiple cellular proteins

The term 'Multiple cellular proteins' is a non-specific designation used in pharmacological databases to describe agents that interact with a wide variety of protein targets rather than a single molecular entity (ChEMBL, 2024). This classification is often applied to highly reactive compounds, such as alkylating agents like cisplatin or cyclophosphamide, which form covalent adducts with various functional groups across numerous cellular proteins (National Cancer Institute, 2023). Because these agents lack selectivity, they disrupt multiple biological pathways simultaneously, which can lead to broad therapeutic effects but also significant systemic toxicity (StatPearls, 2023). In clinical practice, the lack of a specific target makes it difficult to predict off-target effects and develop precision medicine approaches. Consequently, this term is typically used for drugs with broad-spectrum activity or those whose precise molecular interactions are too numerous or poorly defined to be listed individually (DrugBank Online, 2024). These agents often target structural proteins, enzymes, and signaling molecules indiscriminately, leading to widespread cellular dysfunction. This lack of specificity is a hallmark of older cytotoxic therapies and certain chemical disinfectants.

Other names

Various cellular proteinsNon-specific protein targetsMulti-target proteinsUnspecified cellular proteins

Non-specific interaction with various cellular proteins, including covalent cross-linking, alkylation of functional groups, and protein denaturation (National Cancer Institute, 2023).